BCM
DGX icon

Bayesian Capital Management’s Quest Diagnostics DGX Stock Holding History

Bayesian Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,700
Closed -$2.82M – 599
2025
Q2 		$2.82M Buy
+15,700
New +$2.73M 0.45% 56
2025
Q1 		– Sell
-11,800
Closed -$1.78M – 688
2024
Q4 		$1.78M Buy
+11,800
New +$1.84M 0.22% 141
2024
Q3 		– Sell
-8,800
Closed -$1.2M – 760
2024
Q2 		$1.2M Buy
+8,800
New +$1.21M 0.14% 198
2023
Q1 		– Sell
-7,600
Closed -$1.19M – 865
2022
Q4 		$1.19M Buy
7,600
+5,163
+212% +$742K 0.17% 146
2022
Q3 		$299K Sell
2,437
-434
-15% -$57.2K 0.06% 413
2022
Q2 		$382K Buy
+2,871
New +$391K 0.07% 401
2021
Q4 		– Sell
-1,600
Closed -$232K – 414
2021
Q3 		$232K Buy
+1,600
New +$234K 0.07% 319
2020
Q4 		– Sell
-13,463
Closed -$1.54M – 502
2020
Q3 		$1.54M Buy
13,463
+10,163
+308% +$1.2M 0.38% 63
2020
Q2 		$376K Buy
+3,300
New +$350K 0.08% 303
2020
Q1 		– Sell
-8,900
Closed -$950K – 814
2019
Q4 		$950K Buy
8,900
+2,200
+33% +$229K 0.16% 186
2019
Q3 		$717K Buy
+6,700
New +$688K 0.14% 210
2017
Q3 		– Sell
-2,900
Closed -$322K – 519
2017
Q2 		$322K Buy
+2,900
New +$307K 0.12% 274

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bayesian Capital Management's DGX Position: Q3 2025 in Review

Bayesian Capital Management sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 15,700 shares — an estimated $2.82M sold.

Bayesian Capital Management first reported a position in DGX in Q2 2017 and held it in 12 quarters. The position peaked at $2.82M in Q2 2025. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Bayesian Capital Management reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 15,700 Quest Diagnostics shares in Q3 2025, an estimated $2.82M.
  • Bayesian Capital Management first reported a position in Quest Diagnostics in Q2 2017 and held it in 12 quarters.
  • Bayesian Capital Management's Quest Diagnostics position peaked at $2.82M in Q2 2025.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.